Fangzhou and Tencent Roll Out AI for Chronic Care, Connecting Hospitals and Homes Across China

Fangzhou and Tencent debut an AI-driven chronic care stack linking hospital-to-home workflows, MLOps, and secure data. Early use shows patient engagement and clearer lab insights.

Categorized in: AI News Healthcare Management
Published on: Nov 28, 2025
Fangzhou and Tencent Roll Out AI for Chronic Care, Connecting Hospitals and Homes Across China

Fangzhou and Tencent Launch AI + Chronic Disease Management: What Healthcare Leaders Need to Know

Fangzhou Inc. and Tencent Healthcare have launched a full-stack "AI + Chronic Disease Management" solution for China's healthcare sector. It connects model training, scenario validation, and deployment into one pipeline, built for scale and day-to-day clinical operations.

The solution runs on Fangzhou's AI+H2H (Hospital to Home) ecosystem, embedding large-model capabilities into chronic care workflows. Tencent Cloud provides cloud, data, and AI infrastructure to keep performance stable at production scale.

What's in the solution

  • AI+H2H workflow integration: Support for hospital-to-home journeys across screening, treatment plans, follow-up, and ongoing monitoring.
  • End-to-end MLOps on Tencent's TI platform: One-stop training, evaluation, and deployment with continuous optimization.
  • High-speed knowledge retrieval: A Tencent Healthcare vector database storing hundreds of billions of medical knowledge entries enables millisecond-level semantic search to improve factuality for RAG-based outputs.
  • Security and compliance: An AI security WAF provides fine-grained threat detection and encrypted protection of sensitive medical data.

Leadership perspective

Dr. Xie Fangmin, Founder, Chairman, and CEO of Fangzhou, said: "By combining Fangzhou's specialized healthcare and chronic disease management expertise with Tencent Healthcare's industrial-grade infrastructure, we are bringing validated, scalable AI capabilities to the entire healthcare ecosystem, and setting a new standard for the evolution of chronic-disease management in China."

Early traction: patient-facing use cases

Fangzhou's "medical report interpretation" feature, launched in October, has seen strong uptake. Patients use it to make sense of lab results, and engagement metrics show more frequent sessions and higher confidence in AI support.

Reliability first: guardrails that matter

  • Reduced hallucinations: Reinforcement learning with curated medical knowledge, rule-based supervision, and scenario alignment checks.
  • Auditability and safety: Evaluation pipelines on the TI platform plus retrieval that prioritizes factual sources.
  • Data protection: Encrypted flows with AI security WAF and threat detection that meet clinical AI compliance requirements.

Why this matters for healthcare management

Chronic care is heavy on coordination costs. A platform that ties clinical guidance, follow-up tasks, and patient education together can lift staff efficiency and improve continuity of care without expanding headcount.

H2H workflows are the difference-maker. If AI plugs into discharge planning, medication titration, and remote follow-up, you get fewer avoidable readmissions and more consistent outcomes at population scale.

Policy fit

The launch supports recent guidance from the National Health Commission on safe, standardized "AI + healthcare" applications and contributes to long-term goals set out under Healthy China 2030.

How to evaluate and implement (quick checklist)

  • Pick one high-volume scenario first: Examples: hypertension follow-up, diabetes SMBG titration, COPD exacerbation alerts, or lab report explanation.
  • Define hard KPIs: Readmission rate (30/90 days), time-to-follow-up, therapy adherence, patient-reported understanding of care plans, and staff time saved per case.
  • Data readiness: Map data sources, consent flows, and retention policies. Confirm secure connectors to EHR, LIS, pharmacy, and patient apps.
  • Clinical governance: Set up a safety committee, escalation rules, and human-in-the-loop approvals where impact is high (e.g., medication changes).
  • Vendor diligence: Ask for latency targets, uptime SLAs, audit logs, versioning policy, bias checks, and cost per active patient per month with projected ROI.
  • Deploy in weeks, iterate monthly: Run A/B or stepped-wedge pilots. Review errors, adjust prompts/knowledge sources, and push updates on a defined cadence.

Technology highlights to probe with your team

  • Retrieval quality: How often does the system cite source context? What is the precision/recall of the vector search on real clinical queries?
  • Evaluation suite: Are there scenario-specific test sets (e.g., CKD staging, insulin titration) with baselines you can review?
  • Security posture: Evidence of encryption in transit/at rest, WAF policies, data residency, and role-based access controls.
  • Integration path: Available APIs/SDKs, event triggers for follow-ups, and support for existing care-management tools.

Company snapshot

Tencent Healthcare: Tencent's healthcare service platform that leverages the WeChat ecosystem and AI to deliver integrated services across care settings.

Fangzhou Inc. (HKEX: 06086): A leading online chronic disease management platform in China, serving 52.8 million registered users and 229,000 physicians as of June 30, 2025. The company focuses on AI-enabled precision medicine and ongoing care.

If you're building internal AI capability

For teams standing up governance, evaluation, and deployment skills, here's a practical starting point for role-based learning: AI courses by job function.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)
Advertisement
Stream Watch Guide
🎉 Black Friday Deal! Get 86% OFF - Limited Time Only!
Claim Deal →